LiveDrive AI: A Pilot Study of a Machine Learning-Powered Diagnostic System for Real-Time, Non-Invasive Detection of Mild Cognitive Impairment
Alzheimer’s disease (AD) represents a significant global health issue, affecting over 55 million individuals worldwide, with a progressive impact on cognitive and functional abilities. Early detection, particularly of mild cognitive impairment (MCI) as an indicator of potential AD onset, is crucial...
Saved in:
Main Authors: | Firas Al-Hindawi, Peter Serhan, Yonas E. Geda, Francis Tsow, Teresa Wu, Erica Forzani |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-01-01
|
Series: | Bioengineering |
Subjects: | |
Online Access: | https://www.mdpi.com/2306-5354/12/1/86 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Blood-based biomarkers in mild behavioral impairment: an updated overview
by: Efthalia Angelopoulou, et al.
Published: (2025-02-01) -
Quality of Life in Mild Cognitive Impairment and Mild Dementia Associated with Alzheimer’s Disease: A Systematic Review
by: Joanna Campbell, et al.
Published: (2024-11-01) -
Functional and effective EEG connectivity patterns in Alzheimer’s disease and mild cognitive impairment: a systematic review
by: Elizabeth R. Paitel, et al.
Published: (2025-02-01) -
Deficits in reaching movements under visual interference as a novel diagnostic marker for mild cognitive impairment
by: Ciro Rosario Ilardi, et al.
Published: (2025-01-01) -
Exploring the ability of plasma pTau217, pTau181 and beta-amyloid in mirroring cerebrospinal fluid biomarker profile of Mild Cognitive Impairment by the fully automated Lumipulse® platform
by: Marcella Catania, et al.
Published: (2025-01-01)